Aspirin is known to lower risk for some cancers, and a new UCSF-led study points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells in at least one pre-cancerous condition.
June 18, 2013
April 29, 2013
Surgery is often recommended for skin cancers, but older, sicker patients can endure complications as a result and may not live long enough to benefit from the treatment.
April 17, 2013
Smoking tobacco through a hookah is gaining popularity among the college crowd, but UCSF researchers have found that hookah smoke contains a different – but still harmful – mix of toxins than cigarettes.
April 08, 2013
A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to UCSF doctors who led the research.
April 04, 2013
Five distinguished UCSF scientists, including three Nobel laureates, are being inducted into the prestigious inaugural class of fellows of the American Association for Cancer Research Academy.
February 12, 2013
Stem cells of the aging bone marrow recycle their own molecules to survive and keep replenishing the blood and immune systems as the body ages, UCSF researchers have discovered.
January 09, 2013
Researchers have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug – an observation that may have important implications for the lives of patients with late-stage disease.
January 07, 2013
The National Cancer Institute has awarded the UCSF Helen Diller Family Comprehensive Cancer Center a $36 million support grant that will fund infrastructure for clinical trials, cutting-edge research and programmatic support over five years.
January 04, 2013
A team of UCSF researchers have conducted the most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness.
December 06, 2012
The rate of cancer survival is expected to keep climbing in coming years largely thanks to research discoveries that are translating into new cancer drugs, which currently account for roughly 30 percent of the pharmaceutical dollar, the chief scientific officer at Bristol-Myers Squib recently said at a showcase event for the UCSF Helen Diller Family Comprehensive Cancer Center.